*Medtronic Plc (MDT) Stake Maintained by Boston Partners

Medtronic plc (NYSE:MDT) Corporate LogoBig Money Sentiment increased to 1.23 in Q4 2018. It has change of 0.16, from 2018Q3’s 1.07. The ratio is positive due to MDT positioning: 67 sold and 384 reduced. 127 funds bought positions and 426 increased positions. Investors holded 1.02 billion in 2018Q3 but now own 1.04 billion shares or 1.67% more. Lazard Asset Lc stated it has 22.89M shs or 4.26% of all its holdings. Aviva Public Limited Com invested 0.5% of its capital in Medtronic plc (NYSE:MDT). Moreover, Acg Wealth has 0.04% invested in Medtronic plc (NYSE:MDT) for 3,063 shs. Smith Moore And Co has invested 0.21% of its capital in Medtronic plc (NYSE:MDT). Louisiana-based Orleans Management La has invested 0.29% in Medtronic plc (NYSE:MDT). Ogorek Anthony Joseph New York Adv holds 5,965 shs or 0.43% of its capital. Tradewinds Management Limited Com has invested 0.01% of its capital in Medtronic plc (NYSE:MDT). Tiedemann Ltd Liability Corp holds 0.05% or 10,698 shs in its capital. 18,769 were accumulated by Neville Rodie & Shaw. North Star Asset Mgmt Incorporated reported 0.04% in Medtronic plc (NYSE:MDT). Ftb has 0.13% invested in Medtronic plc (NYSE:MDT). Allsquare Wealth Mngmt Limited Liability Com has 0.07% invested in Medtronic plc (NYSE:MDT) for 901 shs. Prospector Ptnrs Ltd owns 78,800 shs. Santa Barbara Asset Mgmt Ltd Company invested 2.2% in Medtronic plc (NYSE:MDT). Balasa Dinverno And Foltz Ltd Com has 0.06% invested in Medtronic plc (NYSE:MDT).

In Medtronic Plc (MDT) was increased the stake owned by Boston Partners. The decrease is 11.05% according to 2018Q4 Securities and Exchange form. By buying 734,286 shares Boston Partners made the stock sank with 3.23%. The institutional investor is holding 7.38M shares, compared to the 6.64 million from the previous quarter. And the announced value of the electromedical & electrotherapeutic apparatus company is $671.01M for the 2018Q4. Medtronic Plc has $122.15B market cap. The stock increased 1.25% or $1.12 during the last trading session, touching $91.08.Currently Medtronic plc is uptrending after 17.87% change in last March 30, 2018. MDT has 4.74M shares volume. MDT outperformed by 13.50% the S&P 500.

According to a filing Boston Partners decreased its stake in Spdr S&P 500 Etf Tr (SPY) by 55,122 shares to 2,070 shares, valued at $517,000 in 2018Q4. The fund manages about $53.18 billion and $69.59 billion US Long portfolio. For a total of 39.60M shares it reduced its holding in Cemex Sab De Cv (NYSE:CX) by 13.95 million shares in the quarter, and has cut its stake in Johnson & Johnson (NYSE:JNJ).

For more Medtronic plc (NYSE:MDT) news announced briefly go to: Seekingalpha.com, Globenewswire.com, Seekingalpha.com, Seekingalpha.com or Investorplace.com. The titles are as follows: “Medtronic: Investment ‘Trifecta’ Could Result In Outstanding Returns – Seeking Alpha” announced on March 26, 2019, “Medtronic Evolut Low Risk Trial Meets Primary Endpont – GlobeNewswire” on March 16, 2019, “Medtronic to buy back additional $6B of stock – Seeking Alpha” with a publish date: March 08, 2019, “Medtronic’s TYRX successful in Phase 4 study – Seeking Alpha” and the last “3 Big Stock Charts for Friday: Medtronic, LKQ and Lamb Weston – Investorplace.com” with publication date: March 15, 2019.

Medtronic plc (NYSE:MDT) Ratings Coverage

In total 12 analysts cover Medtronic (NYSE:MDT). “Buy” rating has 9, “Sell” are 0, while 3 are “Hold”. (NYSE:MDT) has 75% bullish analysts. 20 are the (NYSE:MDT)’s ratings reports on 30 Mar 2019 according to StockzIntelligence Inc. On Tuesday, January 15 the stock has “Buy” rating by BTIG Research. On Tuesday, February 19 the company was maintained by Needham. On Monday, October 8 Argus Research maintained Medtronic plc (NYSE:MDT) rating. Argus Research has “Buy” rating and $120 target. In Wednesday, January 2 report Morgan Stanley maintained the stock with “Equal-Weight” rating. On Wednesday, February 20 the stock of Medtronic plc (NYSE:MDT) has “Hold” rating given by Northland Capital. On Wednesday, November 21 the stock has “Outperform” rating by Raymond James. In Monday, March 18 report Northland Capital maintained it with “Hold” rating and $84 target. In Wednesday, February 20 report Credit Suisse maintained the stock with “Buy” rating. In Wednesday, December 19 report JP Morgan upgraded the stock to “Overweight” rating. On Wednesday, January 2 the stock of Medtronic plc (NYSE:MDT) has “Neutral” rating given by Citigroup.

Medtronic plc (NYSE:MDT) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.